Skip to main content
. 2011 May 6;301(1):H87–H97. doi: 10.1152/ajpheart.01206.2010

Table 1.

Final body weight, heart-to-body weight ratio, kidney-to-body weight ratio, and blood pressure values at the end of 6 wk of treatment

SHRSP SHRSP + DOX WKY Rats WKY Rats + DOX
Final body weight 261 ± 7 266 ± 4 265 ± 5 270 ± 6
Heart-to-body weight ratio 0.50 ± 0.02* 0.44 ± 0.01* 0.32 ± 0.01 0.31 ± 0.01
Kidney-to-body weight ratio 0.97 ± 0.02* 1.00 ± 0.02* 0.67 ± 0.01 0.73 ± 0.01
Systolic srterial pressure 184 ± 3 193 ± 3 N/A N/A
Diastolic arterial pressure 128 ± 2 135 ± 2 N/A N/A
Mean arterial pressure 156 ± 3 164 ± 2 N/A N/A
Heart rate 311 ± 5 321 ± 1 N/A N/A

Values are means ± SE. Data were analyzed by one-way ANOVA. DOX, doxycycline; N/A, not applicable.

*

P < 0.05, statistically different from normotensive Wystar Kyoto (WKY) rats;

P < 0.05, statistically different from untreated stroke-prone spontaneously hypertensive rats (SHRSP);

P < 0.05, statistically different from untreated WKY rats.